Methodological Issues in Systematic Review Formulating Questions - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Methodological Issues in Systematic Review Formulating Questions

Description:

What is the efficacy or association of omega-3 fatty acids (DHA, EPA or ALA ... a-linolenic acid [ALA] (walnut, canola oil, flax seed, etc.) Outcomes (endpoints) ... – PowerPoint PPT presentation

Number of Views:62
Avg rating:3.0/5.0
Slides: 13
Provided by: jl374
Category:

less

Transcript and Presenter's Notes

Title: Methodological Issues in Systematic Review Formulating Questions


1
Methodological Issues in Systematic Review-
Formulating Questions -
  • Joseph Lau, MD
  • Tufts Medical Center EPC
  • AHRQ Annual Meeting
  • September 10, 2008

2
(No Transcript)
3
Analytic framework for omega-3 FA intake and CVD
4
Specific Key Questions
  • What is the efficacy or association of omega-3
    fatty acids (DHA, EPA or ALA supplements, and
    fish consumption) in reducing CVD events
    (including all-cause mortality, CVD mortality,
    non-fatal CVD events, and new diagnosis of CVD)?
    In patients without known CVD (primary
    prevention) and with known CVD (secondary
    prevention).

5
Specific Key Questions
  • 2. Relative effects of omega-3 fatty acid
    sources, with specific emphasis on compositions,
    dosages, the ratio of omega-6 to omega-3 fatty
    acids, and potential interactions due to duration
    of intervention or exposure.
  • What adverse events related to omega-3 fatty acid
    dietary supplements are reported in studies?

6
Participants
  • Primary Prevention - patients without prior
    history of cardiovascular disease
  • Country
  • Background diet
  • Secondary Prevention patients with prior
    history of cardiovascular disease

7
Interventions
  • Fish
  • Different kinds, preparation, amount, how intake
    was estimated
  • Fish oil supplements
  • Eicosapentaenoic acid (EPA) / Docosahexaenoic
    acid (DHA)
  • a-linolenic acid ALA (walnut, canola oil, flax
    seed, etc.)

8
Outcomes (endpoints)
  • Clinical outcomes (events)
  • Overall mortality
  • Stroke
  • Myocardial infarction
  • Sudden death
  • revascularization
  • Surrogate/intermediate outcomes (biomarkers,
    measurements)
  • Blood pressure
  • Lipid levels

9
The PICO method to formulate research question on
interventions
10
Study design
  • RCT
  • Cohort
  • Case-control
  • Cross-sectional
  • Other criteria
  • Study size
  • Year, language, etc

11
Additional inclusion criteria
  • Published English language literature
  • Experimental or observational studies
  • Reported original CVD outcome data and evaluated
    any potential source of omega-3 fatty acids
  • At least 5 human subjects
  • At least 1-year duration

12
Issues in formulating a question
  • Narrow versus broad (for individual or
    population)
  • Clinically meaningful and useful (based on sound
    biological and epidemiological principles)
  • Very broadly defined questions may be criticized
    for mixing apples and oranges
  • Very narrowly focused questions may have no data
    or have limited generalizability and sometimes
    may lead to misinterpretations
Write a Comment
User Comments (0)
About PowerShow.com